HIGHFDA DRUG

Major Pharmaceuticals Chlorpromazine Hydrochloride 100 mg Recall 2025 — 866 Blister Packs Nationwide

Major Pharmaceuticals recalled 866 Chlorpromazine Hydrochloride 100 mg tablets distributed nationwide after CGMP deviations allowed N-Nitroso Desmethyl Chlorpromazine above the recommended intake limit. The impurity detected raises safety concerns for ongoing use. Stop using the product immediately and contact Harvard Drug Group LLC dba Major Pharmaceuticals or Rugby Laboratories for guidance and,

Official notice

Source-backed recall notice

No product image was available from the source feed.

Official source
FDA DRUG
Recall date
September 12, 2025
Status
ACTIVE
Severity
6/10

Quick Facts at a Glance

Recall Date
September 12, 2025
Hazard Level
HIGH
Brands
Major Pharmaceuticals, Chlorpromazine Hydrochloride
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL

What to Do Now

Use this page like a recall checklist: verify the product first, then act on the official remedy.

Immediate steps

  1. 1Stop using the product until you confirm whether it is included in the recall.
  2. 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
  3. 3Follow the official remedy from FDA - Drug Safety; save photos, receipts, labels, and correspondence before contacting the company.
  4. 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.

Check these identifiers

Brand
Major Pharmaceuticals, Chlorpromazine Hydrochloride
Product type
Chlorpromazine Hydrochloride Tablets, USP 100 mg
Model numbers
N01920, N02023, N02202
UPC codes
0904-7129, 0904-7130, 0904-7131, 0904-7132, 0904-7133, 0904-7129-61, 0904-7130-61, 0904-7130-06 +4 more
Sold at
Multiple Retailers
Where affected
ALL

Recall Timeline

Key dates and source checks for this recall record.

  1. Recall announced

    September 12, 2025

  2. Reported by FDA DRUG

    October 15, 2025

  3. RecallRadar source check

    April 18, 2026

  4. Consumer action

    Use the official remedy and keep documentation.

Hazard Information

CGMP Deviations: Presence of N-Nitroso Desmethyl Chlorpromazine above the recommended intake limit

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories or your healthcare provider for guidance. Notification method: Letter

About This Product

Chlorpromazine hydrochloride is a prescription antipsychotic used to treat certain psychiatric conditions. The tablets are Rx-only and distributed nationwide.

Why This Is Dangerous

N-nitroso impurities are potential carcinogens. The recall cites an impurity level above the recommended intake limit, prompting cessation of use.

Industry Context

This recall is not described as part of a broader industry pattern in the provided data.

Real-World Impact

Patients taking the medication may be affected nationwide. Immediate action is required to stop using the product and contact providers for guidance and refunds.

Practical Guidance

How to identify if yours is affected

  1. Verify NDC 0904-7132-61 on the packaging.
  2. Check packaging for 100 mg strength and 100 tablets per blister pack (10x10).
  3. Look for model numbers N01920, N02023, or N02202 on the product or packaging.

Where to find product info

Packaging, patient information leaflets, and the FDA recall page for D-0012-2026.

What timeline to expect

Refund/replacement processing times are not specified in the recall notice.

If the manufacturer is unresponsive

  • Document all contact attempts.
  • File a complaint with the FDA if the company remains unresponsive.
  • Consult your pharmacist or physician for alternatives.

How to prevent similar issues

  • Only obtain prescriptions through licensed pharmacies.
  • Check NDC and lot numbers before consuming any medication.
  • Be vigilant for recalls on Rx medications and verify with your pharmacist regularly.

Documentation advice

Keep the recall notification, photos of packaging and labels, and records of all communications with the manufacturer or provider.

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Product Details

Brand: Major Pharmaceuticals. Product: Chlorpromazine Hydrochloride Tablets, USP, 100 mg, 100 tablets. Packaging: 100 tablets per blister, 10x10 blister packs. NDC: 0904-7132-61. UPC: (01)00309047132614. Quantity recalled: 866 blister packs. Sold/distributed: Nationwide. Rx status: Rx Only. Distributor/Manufacturer: The Harvard Drug Group LLC dba Major Pharmaceuticals; Rugby Laboratories; Major Pharmaceuticals, Indianapolis, IN 46268, USA. Recall date: 2025-09-12. Status: Active. Model numbers: N01920, N02023, N02202.

Reported Incidents

No injuries or incidents have been reported.

Key Facts

  • 866 blister packs recalled
  • Model numbers N01920, N02023, N02202
  • Hazard: N-Nitroso Desmethyl Chlorpromazine impurity above intake limit
  • Recall date 2025-09-12; status Active

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
6/ 10
Affected Groups
GENERAL
Injury Types
POISONING

Product Classification

Product TypeChlorpromazine Hydrochloride Tablets, USP 100 mg
Sold At
Multiple Retailers

Product Details

Model Numbers
N01920
N02023
N02202
UPC Codes
0904-7129
0904-7130
0904-7131
+9 more
Affected States
ALL
Report Date
October 15, 2025
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls